The Department of Justice announced a $14.1 million settlement with Complete Health Partners Holdings, a Florida management services organization, to resolve allegations under the False Claims Act. The settlement, finalized August 4, 2026, addresses compliance failures at the MSO level that likely involve arrangements affecting federal health programs. The case highlights enforcement risks for management services organizations operating in or adjacent to Medicaid managed care markets. Specific compliance program deficiencies leading to the settlement offer instructive lessons for MSOs, Medicaid health plans, and affiliated provider organizations subject to federal fraud and abuse laws.
Why it mattersThe settlement demonstrates DOJ and OIG enforcement reach into MSO arrangements that may structure Medicaid managed care provider networks, creating compliance and liability risk for plans relying on such organizations.
Managed Care
The American Cancer Society Cancer Action Network and 128 other advocacy and professional groups submitted a comment letter to HHS OIG on August 24, 2026, requesting a new safe harbor under the federal anti-kickback statute. The proposed safe harbor would allow clinical trial sponsors to cover participants' travel, lodging, and other expenses without exposure to fraud and abuse liability. The comment period timing suggests OIG is considering rulemaking on this issue. For Medicaid providers participating in clinical trials, this matters because current anti-kickback constraints limit their ability to cover beneficiary costs, potentially reducing trial participation among Medicaid populations who face the greatest financial barriers to access.
Why it mattersMedicaid providers and health plans conducting or facilitating clinical trials face legal uncertainty when covering patient costs that could improve trial access for beneficiaries who disproportionately face financial barriers to participation.
Managed Care
Monogram Health, a home health company, will pay $2.4 million to settle Justice Department allegations that it overcharged Medicare Advantage plans through inflated diagnostic codes in contracts with Cigna and Humana. The settlement resolves claims that Monogram systematically upcoded patient diagnoses to increase risk-adjusted payments to MA plans. The enforcement action reflects continued federal scrutiny of diagnosis coding practices in Medicare Advantage, particularly involving delegated provider arrangements that impact plan payments.
Why it mattersThis settlement underscores federal enforcement focus on risk adjustment accuracy in delegated arrangements, a compliance model with parallels in Medicaid managed care where plans similarly contract with third-party providers for care delivery and coding.
Managed Care